scispace - formally typeset
Open AccessJournal Article

Marine natural products as anticancer drugs

TLDR
This review highlights several marine natural products and their synthetic derivatives that are currently undergoing clinical evaluation as anticancer drugs.
Abstract
The chemical and biological diversity of the marine environment is immeasurable and therefore is an extraordinary resource for the discovery of new anticancer drugs. Recent technological and methodologic advances in structure elucidation, organic synthesis, and biological assay have resulted in the isolation and clinical evaluation of various novel anticancer agents. These compounds range in structural class from simple linear peptides, such as dolastatin 10, to complex macrocyclic polyethers, such as halichondrin B; equally as diverse are the molecular modes of action by which these molecules impart their biological activity. This review highlights several marine natural products and their synthetic derivatives that are currently undergoing clinical evaluation as anticancer drugs.

read more

Citations
More filters
Journal ArticleDOI

In Vitro Cytotoxic Activity of Isostichopus badionotus, a Sea Cucumber from Yucatan Peninsula Coast

TL;DR: The in vitro cytotoxic activity of hexane, ethyl acetate and butanol extracts of the sea-cucumber Isostichopus badionotus (Holothuroidea) was tested against normal cells, human cervical carcinoma and breast adenocarcinoma and ATCC cells by 3-(4,5-dimethylthiazol-2-yl)-2-diphenyl tetrazolium bromide (MTT) assay.
Dissertation

Proteomic investigation of an Escherichia coli terpene production factory: prospects for metabolic engineering

F.O. Robert
TL;DR: This study demonstrates the importance of systems level –omic analyses in shedding light on bottlenecks that prevent commercially viable synthesis of highly beneficial natural products like terpene with E. coli as a biological chassis.

Interactive Domains in the Molecular Chaperone Human aB Crystallin Modulate Microtubule Assembly and

TL;DR: These are the first experimental results in support of the functional importance of the dynamic subunit model of small heat shock proteins, which depends on the concentration and ratio of aB crystallin to tubulin.
References
More filters
Journal ArticleDOI

Natural Products as Sources of New Drugs over the Period 1981−2002

TL;DR: From the data presented, the utility of natural products as sources of novel structures, but not necessarily the final drug entity, is still alive and well, and in the area of cancer, the percentage of small molecule, new chemical entities that are nonsynthetic has remained at 62% averaged over the whole time frame.
Journal ArticleDOI

Marine Natural Products and Related Compounds in Clinical and Advanced Preclinical Trials

TL;DR: There are now significant numbers of very interesting molecules that have come from marine sources, or have been synthesized as a result of knowledge gained from a prototypical compound, that are either in or approaching Phase II/III clinical trials in cancer, analgesia, allergy, and cognitive diseases.
Journal ArticleDOI

Tubulin as a target for anticancer drugs: agents which interact with the mitotic spindle.

TL;DR: This review describes the biochemistry of tubulin, microtubules, and the mitotic spindle and describes the natural and synthetic agents which are known to interact with tubulin.
Related Papers (5)